Transporters in Drug-Refractory Epilepsy: Clinical Significance
نویسندگان
چکیده
منابع مشابه
Drug Refractory Localisation Related Epilepsy
service Email alerting top right corner of the article Receive free email alerts when new articles cite this article-sign up in the box at the
متن کاملRenal drug transporters and their significance in drug–drug interactions
The kidney is a vital organ for the elimination of therapeutic drugs and their metabolites. Renal drug transporters, which are primarily located in the renal proximal tubules, play an important role in tubular secretion and reabsorption of drug molecules in the kidney. Tubular secretion is characterized by high clearance capacities, broad substrate specificities, and distinct charge selectivity...
متن کاملDrug and Substance Abuse in Refractory Epilepsy
Drugs and substances abuse in patients with refractor epilepsy were investigated in this study which includes 924 patients with intractable epilepsy were studied for serum levels of antiepileptic drugs and for drugs and substances abuse. Positive results for abuse were detected in 246 patients (26.62%), 56.5% of them were in the age group 20 – 30 years. Males outnumbered females with a sex rati...
متن کاملDrug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.
Epilepsy is resistant to drug treatment in about one-third of cases, but the mechanisms underlying this drug resistance are not understood. In cancer, drug resistance has been studied extensively. Amongst the various resistance mechanisms, overexpression of drug resistance proteins, such as multi-drug resistance gene-1 P-glycoprotein (MDR1) and multidrug resistance-associated protein 1 (MRP1), ...
متن کاملTreating refractory epilepsy with tiagabine: clinical experience
Epilepsy remains difficult to treat with more than 30% of patients being refractory to conventional anticonvulsant therapy. Combination therapy may improve seizure control in some of these patients. Tiagabine is a new anticonvulsant that has a unique mechanism of action as a selective gamma-aminobutyric acid (GABA) re-uptake inhibitor (SGRI). Twenty consecutive patients with refractory epilepsy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Pharmacology & Therapeutics
سال: 2010
ISSN: 0009-9236,1532-6535
DOI: 10.1038/clpt.2009.225